These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33294799)

  • 21. Key Intermediate Species Reveal the Copper(II)-Exchange Pathway in Biorelevant ATCUN/NTS Complexes.
    Kotuniak R; Strampraad MJF; Bossak-Ahmad K; Wawrzyniak UE; Ufnalska I; Hagedoorn PL; Bal W
    Angew Chem Int Ed Engl; 2020 Jul; 59(28):11234-11239. PubMed ID: 32267054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence-Activity Relationship of ATCUN Peptides in the Context of Alzheimer's Disease.
    Lefèvre M; Malikidogo KP; Esmieu C; Hureau C
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of β-Alanine in Cu(II) ATCUN Peptide Complexes Increases ROS Levels, DNA Cleavage and Antiproliferative Activity.
    Heinrich J; Bossak-Ahmad K; Riisom M; Haeri HH; Steel TR; Hergl V; Langhans A; Schattschneider C; Barrera J; Jamieson SMF; Stein M; Hinderberger D; Hartinger CG; Bal W; Kulak N
    Chemistry; 2021 Dec; 27(72):18093-18102. PubMed ID: 34658072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of West Nile Virus NS2B/NS3 Protease by Amino Terminal Copper and Nickel Binding (ATCUN) Peptides.
    Pinkham AM; Yu Z; Cowan JA
    J Med Chem; 2018 Feb; 61(3):980-988. PubMed ID: 29301071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorophore ATCUN complexes: combining agent and probe for oxidative DNA cleavage.
    Wende C; Kulak N
    Chem Commun (Camb); 2015 Aug; 51(62):12395-8. PubMed ID: 26143739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of N-heteroaromatic N-termini in Cu(II) ATCUN metallopeptides on their biorelevant redox activity.
    Barrera J; H Haeri H; Heinrich J; Stein M; Hinderberger D; Kulak N
    Dalton Trans; 2023 Mar; 52(11):3279-3286. PubMed ID: 36633467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A luminescent ATCUN peptide variant with enhanced properties for copper(II) sensing in biological media.
    Falcone E; Vileno B; Hoang M; Raibaut L; Faller P
    J Inorg Biochem; 2021 Aug; 221():111478. PubMed ID: 33975250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanostructure and dynamics of N-truncated copper amyloid-β peptides from advanced X-ray absorption fine structure.
    Ekanayake RSK; Streltsov VA; Best SP; Chantler CT
    IUCrJ; 2024 May; 11(Pt 3):325-346. PubMed ID: 38602752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the Molybdenum/Copper Heterometallic Cluster Assembly in the Orange Protein: Probing Intermolecular Interactions with an Artificial Metal-Binding ATCUN Tag.
    Maiti BK; Almeida RM; Maia LB; Moura I; Moura JJG
    Inorg Chem; 2017 Aug; 56(15):8900-8911. PubMed ID: 28742344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of Cu(II) complexation by ATCUN/NTS and related peptides: a gold mine of novel ideas for copper biology.
    Kotuniak R; Bal W
    Dalton Trans; 2021 Dec; 51(1):14-26. PubMed ID: 34816848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence proximity between Cu(II) and Cu(I) binding sites of human copper transporter 1 model peptides defines reactivity with ascorbate and O2.
    Schwab S; Shearer J; Conklin SE; Alies B; Haas KL
    J Inorg Biochem; 2016 May; 158():70-76. PubMed ID: 26778425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino Terminal Copper and Nickel Binding Motif Derivatives of Ovispirin-3 Display Increased Antimicrobial Activity via Lipid Oxidation.
    Alexander JL; Yu Z; Cowan JA
    J Med Chem; 2017 Dec; 60(24):10047-10055. PubMed ID: 29172482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target-directed catalytic metallodrugs.
    Joyner JC; Cowan JA
    Braz J Med Biol Res; 2013 Jun; 46(6):465-85. PubMed ID: 23828584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of sortase A mediated by metal ATCUN complexes.
    Fidai I; Hocharoen L; Bradford S; Wachnowsky C; Cowan JA
    J Biol Inorg Chem; 2014 Dec; 19(8):1327-39. PubMed ID: 25217034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of a designed cyclic peptide ligand for nickel and copper ions.
    Eshelman MR; Aldous AR; Neupane KP; Kritzer JA
    Tetrahedron; 2014 Oct; 70(42):7651-7654. PubMed ID: 25414527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B.
    Libardo MD; Gorbatyuk VY; Angeles-Boza AM
    ACS Infect Dis; 2016 Jan; 2(1):71-81. PubMed ID: 27622949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper-binding motifs Xxx-His or Xxx-Zzz-His (ATCUN) linked to an antimicrobial peptide: Cu-binding, antimicrobial activity and ROS production.
    Bouraguba M; Glattard E; Naudé M; Pelletier R; Aisenbrey C; Bechinger B; Raibaut L; Lebrun V; Faller P
    J Inorg Biochem; 2020 Dec; 213():111255. PubMed ID: 32980641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of Nanocatalytic Medicine from Self-Assembling Peptides Containing an ATCUN-Like Copper-Binding Motif for Anticancer Therapy.
    Zhang W; Tian X; Li X
    Chembiochem; 2024 Aug; 25(15):e202400216. PubMed ID: 38801354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Peptides and Copper(II) Ions: Novel Therapeutic Opportunities.
    Portelinha J; Duay SS; Yu SI; Heilemann K; Libardo MDJ; Juliano SA; Klassen JL; Angeles-Boza AM
    Chem Rev; 2021 Feb; 121(4):2648-2712. PubMed ID: 33524257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.